Kalaris Therapeutics, Inc. (KLRS)
NASDAQ: KLRS · Real-Time Price · USD
9.82
+0.14 (1.45%)
At close: Mar 6, 2026, 4:00 PM EST
9.50
-0.32 (-3.26%)
After-hours: Mar 6, 2026, 6:35 PM EST

Kalaris Therapeutics Analyst Ratings

Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$20.67
Upside
+110.49%

Ratings History

Analyst Firm Rating Rating Action Price Target Upside Date
Chardan Capital
Chardan Capital
Strong Buy
Initiates
$19
Strong Buy Initiates $19 +93.48% Dec 23, 2025
Citizens
Citizens
Buy
Initiates
$20
Buy Initiates $20 +103.67% Nov 3, 2025
Raymond James
Raymond James
Strong Buy
Initiates
$23
Strong Buy Initiates $23 +134.22% Sep 3, 2025
William Blair
William Blair
Buy
Initiates
n/a
Buy Initiates n/a n/a Apr 8, 2025